|
Canada-0-LaboratoriesTesting Azienda Directories
|
Azienda News:
- iPLEDGE REMS - Home
What is the iPLEDGE ® REMS (Risk Evaluation and Mitigation Strategy)? The iPLEDGE REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure
- ipledge
iPledge is a program designed to prevent fetal exposure to isotretinoin through strict guidelines and education for patients, prescribers, and pharmacies
- FDA Approves iPLEDGE REMS Modification
FDA approved modifications to the iPLEDGE Risk Evaluation and Mitigation Strategy (REMS) to minimize burden on patients, prescribers, and pharmacies while maintaining the safe use of isotretinoin
- Fact Sheet for the iPLEDGE Program - My Doctor Online
To get information about the iPLEDGE Program, you should talk to your doctor or visit the iPLEDGE Program website www ipledgeprogram com
- iPLEDGE program - Wikipedia
Isotretinoin may only be dispensed at authorized US pharmacies that are registered with the iPLEDGE Program, and FDA has taken action against Canadian and internet pharmacies which dispense isotretinoin outside of the iPLEDGE Program
- The iPLEDGE Program Patient Introductory Brochure
WHAT IS THE iPLEDGE PROGRAM? The iPLEDGE program is a set of steps all patients, doctors, and pharmacists must follow The main goal is preventing pregnancy and birth defects, but both male patients and female patients must follow the iPLEDGE program
- iPledge Forms
Patients who are able to become pregnant, including those who are pre-pubertal, those not sexually active, and transgender men with viable female reproductive organs Male patients as well as female patients who have had a hysterectomy, bilateral oophorectomy, or medically documented ovarian failure (eg lab-confirmed postmenopausal)
- Questions and Answers on the iPLEDGE REMS | FDA
All isotretinoin manufacturers are part of the iPLEDGE program, and health care providers and pharmacies must be registered with iPLEDGE to be able to prescribe and dispense isotretinoin to
- Most Recent Update: MARCH 2023 - iPLEDGE PROGRAM
The iPLEDGE REMS is a computer-based risk management system that uses verifiable, traceable links between prescriber, patient, pharmacy, and wholesaler to control prescribing, using, dispensing, and distribution of isotretinoin
- Select Authentication System - iPLEDGE PROGRAM
The iPLEDGE PROGRAM REMS (Risk Evaluation and Mitigation Strategy) The iPLEDGE PROGRAM REMS is a safety program to manage the risk of isotretinoin’s teratogenicity and to minimize fetal exposure
|
|